분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2010-11-23 10:49:08 , Hit : 2879
 Why brain tumors hard to treat


Some brain tumor cells develop into blood vessels, forming some of the vasculature needed to support the tumor's growth and challenging conventional wisdom


[Published 21st November 2010 06:00 PM GMT]


--------------------------------------------------------------------------------

New findings may help explain why glioblastomas, one of the most aggressive forms of brain cancer, are often so difficult to treat -- they can feed themselves, by differentiating into the intricate network of blood vessels that nourish the tumor, according to two studies published online today (21 November) in Nature.


Macroscopic pathology of Glioblastoma multiforme
Image: Wikimedia commons,
Sbrandner
These results may help explain the failure of some anti-angiogenesis therapies used to fight glioblastomas, as well as point to new possible cancer treatments that target tumor-derived angiogenesis.

"The general idea is that the vasculature is created by the normal tissue," said cell biologist Angelo Vescovi of the Mendel Institute for Genetics in Rome, who was not involved in the research. But these papers show that "the tumor itself is actually making its own blood vessels. It's a very different way to look at them."

Glioblastomas are noted for their unusual vasculature, characterized by large, highly proliferating cells and abnormal structures. Until now, however, these vessels were thought to be derived from pre-existing brain capillaries, but no one had ever gone in a taken a close look, said neurosurgeon and neuroscientist Viviane Tabar of the Memorial Sloan Kettering Cancer Center in New York.

So she and her colleagues did just that. They looked for mutations known to exist in the tumor cells, including large amplifications and chromosome abnormalities, in the cells of the vasculature to see if they contained a similar genetic signature. Sure enough, a significant proportion of the endothelial cells carried the tumor's mutations, suggesting they originated from the tumor cells.

Meanwhile, on the other side of the Atlantic Ocean, physician and cell biologist Ruggero De Maria of the Istituto Superiore di Sanita in Italy was working with his colleagues to show the exact same thing. Scouring the genomes of the tumor vasculature for aberrations found in the tumor cells themselves, the team found that anywhere from 20 to 90 percent of the blood vessels were indeed tumor-derived. The group was "very surprised," De Maria said.

"I did not expect to find it so obvious in a way," Tabar agreed. "It was nice to see another group independently reached the same conclusion."

To confirm that the tumor cells were indeed capable to differentiating into the mature endothelium of the vasculature, the researchers isolated tumor cells containing markers suggestive of a stem-cell-like state and confirmed their ability to differentiate into endothelial cells. The teams then injected the cells into immunosuppressed mice and analyzed the resulting tumors. Once again, the results were the same: A large percentage of the blood vessels that developed in the tumors were of human, not mouse, origin, indicating that they were derived directly from the tumors themselves.

"The bottom line is we were able to identify blood vessels of human origins in the brains of mice carrying the tumors," Tabar said. "These vessels came from the glioblastoma cells."

The findings may explain why a common drug used to inhibit angiogenesis in cancer patients may not be very effective, she added. After further experiments, "we realized that this drug is not able to inhibit or stop the glioblastoma cells from making blood vessels at all." The drug appears to stop the endothelial cells from maturing, but not the formation of the blood vessels themselves, she explained.
And when De Maria and his colleagues killed the endothelial cells produced by the cancer stem cells, they "observed a stronger regression of the tumor," suggesting tumors need these tumor-derived blood vessels, he said -- and pointing to new potential targets for future drugs that block this process.

The applications may be more widespread than just glioblastomas, Tabar added. "All tumors have blood vessels," she said. "I'm hoping that this will invite researchers to look in other cancers to see if other cancers can use this pathway to derive their own blood vessels."

Researchers also have to learn more about the process itself. Tabar's group showed, for example, that Notch signaling appears to be important for the differentiation into endothelial progenitors, while the VEGF signaling pathway -- targeted by current anti-angiogenesis drugs -- is key for the maturation into adult endothelium. But "this is just the starting point," De Maria said. "We need to determine the pathways and the requirements that push [these cells] towards one pathway -- the production of cancer cells -- or the other pathway -- the production of endothelial cells."

"These kinds of functional studies will reveal that you have very different subtypes within the glioblastoma," Vescovi agreed. "That will tell you something about how the [tumor developed] and how to treat it."

R. Wang, et al., "Glioblastoma stem-like cells give rise to tumour endothelium," Nature, doi:10.1038/nature09624, 2010.

L. Ricci-Vitiani, et al., " Tumour vascularization via endothelial
differentiation of glioblastoma stem-like cells," Nature, doi:10.1038/nature09557, 2010.



Read more: Why brain tumors hard to treat - The Scientist - Magazine of the Life Sciences http://www.the-scientist.com/news/display/57817/#ixzz1649vQFDG







967   Strides Against Hepatitis C Open Door to Blockbusters  이성욱 2010/11/02 2520
966   Black patients fare well on Vertex hepatitis C drug  이성욱 2010/11/02 2656
965   NC State Develops More Precise Genetic ‘Off Switches’  이성욱 2010/11/03 2592
964   Breakthrough in cancer vaccine research  이성욱 2010/11/08 2633
963   DNA sequence may be lost in translation  이성욱 2010/11/10 2738
962   Lung Cancer in Smokers, Nonsmokers May Be a Different Disease  이성욱 2010/11/10 2539
  Why brain tumors hard to treat  이성욱 2010/11/23 2879
960   Vertex submits application for hepatitis C drug  이성욱 2010/11/25 3386
959   Tumours grow their own blood vessels  이성욱 2010/11/25 2308
958   Top 5 papers of 2010  이성욱 2010/12/10 2289
957   Microbe gets toxic response  이성욱 2010/12/10 2424
956   Basel Declaration defends animal research  이성욱 2010/12/10 2316
955   Missing Molecules Hold Promise of Therapy for Pancreatic Cancer: Lost microRNAs Put Brakes on Tumors  이성욱 2010/12/22 2210
954   HIV patient with leukemia treated through stem cell transplant  이성욱 2010/12/23 4967
953   Top 5 papers of 2010  이성욱 2010/12/28 2550
952   Smoking May Worsen Pain For Cancer Patients  이성욱 2010/12/28 2655
951   key interaction in hepatitis C virus  이성욱 2010/12/30 2207
950   Parallels Between Cancers, Infection Suppression: Same Proteins Involved, but Cancer Takes Hold When Response Gets out of Control  이성욱 2011/01/11 2567
949   Cancer Can Develop in Catastrophic Burst  이성욱 2011/01/13 2809
948   Viral Evasion Gene Reveals New Targets for Eliminating Chronic Infections  이성욱 2011/01/17 2299

[이전 10개] [1]..[11][12][13][14][15] 16 [17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN